TSE:CPH - Cipher Pharmaceuticals Stock Price, Forecast & News

Cipher Pharmaceuticals trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CPH."

Cipher Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, March 26th 2020. View Earnings Estimates for Cipher Pharmaceuticals.

2 brokerages have issued twelve-month price objectives for Cipher Pharmaceuticals' shares. Their forecasts range from C$1.50 to C$1.50. On average, they expect Cipher Pharmaceuticals' share price to reach C$1.50 in the next year. This suggests a possible upside of 57.9% from the stock's current price. View Analyst Price Targets for Cipher Pharmaceuticals.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cipher Pharmaceuticals in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cipher Pharmaceuticals.

News headlines about CPH stock have trended very positive this week, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cipher Pharmaceuticals earned a news impact score of 4.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Cipher Pharmaceuticals.

Some companies that are related to Cipher Pharmaceuticals include Depomed (ASRT), Delta 9 Cannabis (NINE), Biosyent (RX), Althea Group (AGH), Invion (IVX), Science in Sport (SIS), InMed Pharmaceuticals (IN), MMJ Group (MMJ), Pediapharm (MDP), cbdMD (YCBD), Zomedica Pharmaceuticals (ZOM), Viridium Pacific Group (VIR), MGC Pharmaceuticals (MXC), Eve & Co Inc (EVE) and Diurnal Group (DNL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cipher Pharmaceuticals investors own include Cipher Pharmaceuticals (CPHRF), Bellatrix Exploration (BXE), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Catalyst Biosciences (CBIO), Ampio Pharmaceuticals (AMPE), NovaBay Pharmaceuticals (NBY), Aurora Cannabis (ACB), Alaris Royalty (AD) and Crescent Point Energy (CPG).

Shares of CPH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

One share of CPH stock can currently be purchased for approximately C$0.95.

Cipher Pharmaceuticals has a market capitalization of C$25.59 million and generates C$22.94 million in revenue each year. Cipher Pharmaceuticals employs 39 workers across the globe.View Additional Information About Cipher Pharmaceuticals.

The official website for Cipher Pharmaceuticals is http://www.cipherpharma.com/.

Cipher Pharmaceuticals' mailing address is 2345 Argentia Rd Suite 100A, MISSISSAUGA, ON L5N 8K4, Canada. The company can be reached via phone at +1-905-6025840.